All

Results: 49933-49944 of 67441

Eisai projects Leqembi® revenue to total JPY 56.5 billion for fiscal year 2024 (April 2024 - March 2025)

Allshares Solidifies Nordic Leadership With the Acquisition of Aktieinvest Incentives

PR Newswire associated0

AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Post-operative Pain

Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for subcutaneous maintenance dosing

PR Newswire associated0

vivo Announces Android 15 Beta Program for Developers on X100 and iQOO 12 Smartphones

Former Microsoft, IBM and Compaq Executive to Head APJ Expansion for GTDC

PR Newswire associated0

Casio to Release G-SHOCK-Surfrider Foundation Collaboration

Actions Technology’s Smart Watch SoC Adopted VeriSilicon’s 2.5D GPU IP

PR Newswire associated0

Wondershare showcases its Enterprise Solution Excellence at VivaTech 2024 in Paris

ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update

ESOC 2024: Higher income reduces stroke mortality risk by a third, new study shows

PR Newswire associated0

TCL CSOT Returns to SID Display Week 2024 with Cutting-Edge Display Products to Empower a Better Life